Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers
Anandasabapathy, N, Breton, G, Hurley, A, Caskey, M, Trumpfheller, C, Sarma, P, Pring, J, Pack, M, Buckley, N, Matei, I, Lyden, D, Green, J, Hawthorne, T, Marsh, H C, Yellin, M, Davis, T, Keler, T, Schlesinger, S J
Published in Bone marrow transplantation (Basingstoke) (01.07.2015)
Published in Bone marrow transplantation (Basingstoke) (01.07.2015)
Get full text
Journal Article
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
Schuster, James, Lai, Rose K, Recht, Lawrence D, Reardon, David A, Paleologos, Nina A, Groves, Morris D, Mrugala, Maciej M, Jensen, Randy, Baehring, Joachim M, Sloan, Andrew, Archer, Gary E, Bigner, Darell D, Cruickshank, Scott, Green, Jennifer A, Keler, Tibor, Davis, Thomas A, Heimberger, Amy B, Sampson, John H
Published in Neuro-oncology (Charlottesville, Va.) (01.06.2015)
Published in Neuro-oncology (Charlottesville, Va.) (01.06.2015)
Get full text
Journal Article
Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity
Trumpfheller, C., Longhi, M. P., Caskey, M., Idoyaga, J., Bozzacco, L., Keler, T., Schlesinger, S. J., Steinman, R. M.
Published in Journal of internal medicine (01.02.2012)
Published in Journal of internal medicine (01.02.2012)
Get full text
Journal Article
A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer
McGray, A. J. R., Eppolito, C., Miliotto, A., Singel, K. L., Stephenson, K., Lugade, A., Segal, B. H., Keler, T., Webster, G., Lichty, B., Kozbor, D., Odunsi, K.
Published in Cancer Immunology, Immunotherapy (01.12.2021)
Published in Cancer Immunology, Immunotherapy (01.12.2021)
Get full text
Journal Article
Determinants of response to T‐cell stimulation by CD27 antibody therapy in lymphoma: The RiVa trial
Rose‐Zerilli, M. J., Buermann, L., Stanton, L., Wignall, C. M., Coleman, A. R., Thorne, K., Keyworth, N., Konn, Z., Turaj, A. H., McKay, P., Osborne, W., Linton, K., Medd, P., Collins, G. P., Keler, T., Yellin, M., Gentles, A., Griffiths, G., Lim, S. H.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
CD27 STIMULATION ENHANCES CD20 MAB THERAPY THROUGH ACTIVATION OF INNATE IMMUNITY
Turaj, A.H., Rose‐Zerilli, M., Cox, K., James, S., Al‐Shamkhani, A., Keler, T., Johnson, P.W., Thirdborough, S.M., Beers, S.A., Glennie, M.J., Cragg, M.S., Lim, S.H.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers
Caskey, M, Trumpfheller, C, Pollak, S, Sinnenberg, L, Hurley, A, Pring, J, Shimeliovich, I, Yipp, B, Anandasabapathy, N, Mehandru, S, Sarma, P, Koup, R, Bailer, R, Tomaras, G, Sato, A, Keler, T, Steinman, R, Schlesinger, S
Published in Retrovirology (13.09.2012)
Published in Retrovirology (13.09.2012)
Get full text
Journal Article
Targeting Weak Antigens to CD64 Elicits Potent Humoral Responses in Human CD64 Transgenic Mice
Keler, Tibor, Guyre, Paul M, Vitale, Laura A, Sundarapandiyan, Karuna, van de Winkel, Jan G. J, Deo, Yashwant M, Graziano, Robert F
Published in The Journal of immunology (1950) (15.12.2000)
Published in The Journal of immunology (1950) (15.12.2000)
Get full text
Journal Article
Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation
Cohn, Lillian, Chatterjee, Bithi, Esselborn, Filipp, Smed-Sörensen, Anna, Nakamura, Norihiro, Chalouni, Cécile, Lee, Byoung-Chul, Vandlen, Richard, Keler, Tibor, Lauer, Peter, Brockstedt, Dirk, Mellman, Ira, Delamarre, Lélia
Published in The Journal of experimental medicine (06.05.2013)
Published in The Journal of experimental medicine (06.05.2013)
Get full text
Journal Article
Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells
Chatterjee, Bithi, Smed-Sörensen, Anna, Cohn, Lillian, Chalouni, Cécile, Vandlen, Richard, Lee, Byoung-Chul, Widger, Jenifer, Keler, Tibor, Delamarre, Lélia, Mellman, Ira
Published in Blood (06.09.2012)
Published in Blood (06.09.2012)
Get full text
Journal Article
Safety and efficacy of CDX-014, an antibody-drug conjugate against T Cell immunoglobulin mucin-1 (TIM-1), in advanced renal cell carcinoma
McGregor, B.A., Agarwal, N., Gordon, M., George, S., Quinn, D.I., Rogalski, M., Keler, T., Hawthorne, T., Choueiri, T.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
953P - Safety and efficacy of CDX-014, an antibody-drug conjugate against T Cell immunoglobulin mucin-1 (TIM-1), in advanced renal cell carcinoma
McGregor, B.A., Agarwal, N., Gordon, M., George, S., Quinn, D.I., Rogalski, M., Keler, T., Hawthorne, T., Choueiri, T.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
953PSafety and efficacy of CDX-014, an antibody-drug conjugate against T Cell immunoglobulin mucin-1 (TIM-1), in advanced renal cell carcinoma
McGregor, B A, Agarwal, N, Gordon, M, George, S, Quinn, D I, Rogalski, M, Keler, T, Hawthorne, T, Choueiri, T K
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
D100 CDX-0159, AN ANTI-KIT MONOCLONAL ANTIBODY, AS A MODULATOR OF MAST CELL-RELATED DISEASES
Seibel, S., Vitale, L., Thomas, L., Goldstein, J., Forsberg, E., Crocker, A., Widger, J., Patterson, C., Mills-Chen, L., Hammond, R., Keler, T., Gedrich, R.
Published in Annals of allergy, asthma, & immunology (01.11.2019)
Published in Annals of allergy, asthma, & immunology (01.11.2019)
Get full text
Journal Article
Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma
SANDERSON, Kristin, SCOTLAND, Ronald, YELLIN, Michael, WEBER, Jeffrey, LEE, Peter, DONGXIN LIU, GROSHEN, Susan, SNIVELY, Jolie, SIAN, Shirley, NICHOL, Geoffrey, DAVIS, Thomas, KELER, Tibor
Published in Journal of clinical oncology (01.02.2005)
Published in Journal of clinical oncology (01.02.2005)
Get full text
Journal Article